Search
for
Sort by
Research 121–150 of 137
- Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy
- Repurposed Drugs: Current Trends in Drug Discovery
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FINASTERIDE, TADALAFIL, AND ITS APPLICATION TO PHARMACOKINETIC STUDIES IN RAT PLASMA BY USING LC-MS/MS
- Bicalutamide: A review
- Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study
- A guide to the use of bioassays in exploration of natural resources
- Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
- Enhancing Solubility and Dissolution Behavior of Finasteride Using Solid Dispersion Technique by Carrier Screening and the New Preparation Instrument
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- CAQ Corner: Basic concepts of transplant immunology
- Skin Disease in Korean Human Immunodeficiency Virus Patient
- Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV‐infected women with and without central lipohypertrophy
- Author Index
- DIETHYLPROPION
- ZALCITABINE
- Generalized hair loss induced by indinavir plus ritonavir therapy
- Alopecia associated with ritonavir-boosted atazanavir therapy
- Alopecia induced by lopinavir plus ritonavir therapy in an HIV patient.
- SAT340 Matters Of The HAART - Ritonavir Induced CYP3A4 Inhibition of Intranasal Fluticasone Leading To Cushing’s Syndrome
- Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency Due to an Interaction Between Fluticasone and Ritonavir
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Hair Loss Induced by Lopinavir-Ritonavir
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Nail, hair and skin hyperpigmentation associated with indinavir therapy
- Raltegravir-Induced Alopecia in an HIV+ Patient
- Balint’s syndrome—missed or mistaken?
- An update of anti-viral treatment of COVID-19
- Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies